GNA13 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.191800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.256300E-02
Normal-vs-Stage2
1.343200E-01
Normal-vs-Stage3
1.415610E-01
Normal-vs-Stage4
4.096000E-01
Stage1-vs-Stage2
1.660010E-01
Stage1-vs-Stage3
8.717600E-01
Stage1-vs-Stage4
2.742400E-02
Stage2-vs-Stage3
3.270600E-01
Stage2-vs-Stage4
1.759000E-01
Stage3-vs-Stage4
2.497600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.167600E-02
Normal-vs-AfricanAmerican
8.672400E-01
Normal-vs-Asian
1.111400E-01
Caucasian-vs-AfricanAmerican
2.975800E-01
Caucasian-vs-Asian
8.496400E-01
AfricanAmerican-vs-Asian
1.828790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.229790E-01
Normal-vs-Female
6.811800E-02
Male-vs-Female
7.996000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.587600E-01
Normal-vs-Age(41-60Yrs)
3.971600E-01
Normal-vs-Age(61-80Yrs)
3.275600E-02
Normal-vs-Age(81-100Yrs)
2.950000E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.291000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.254600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.824400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.987700E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.506000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.619800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.777700E-02
Normal-vs-Daily Drinker
1.749870E-02
Normal-vs-Weekly Drinker
9.342100E-02
Normal-vs-Occasional Drinker
3.604600E-01
Normal-vs-Social Drinker
1.570170E-01
Non Drinker-vs-Daily Drinker
3.560800E-01
Non Drinker-vs-Weekly Drinker
9.174800E-01
Non Drinker-vs-Occasional Drinker
4.711600E-01
Non Drinker-vs-Social Drinker
4.500200E-01
Daily Drinker-vs-Weekly Drinker
3.922600E-01
Daily Drinker-vs-Occasional Drinker
2.057800E-01
Daily Drinker-vs-Social Drinker
1.368400E-01
Weekly Drinker-vs-Occasional Drinker
5.821400E-01
Weekly Drinker-vs-Social Drinker
5.920400E-01
Occasional Drinker-vs-Social Drinker
8.853800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.560000E-01
Normal-vs-Grade 2
1.650960E-01
Normal-vs-Grade 3
1.979790E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.660440E-01
Grade 1-vs-Grade 3
3.210400E-01
Grade 1-vs-Grade 4
4.560000E-01
Grade 2-vs-Grade 3
7.629400E-01
Grade 2-vs-Grade 4
1.650960E-01
Grade 3-vs-Grade 4
1.979790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.689600E-02
Normal-vs-NonDiabetic
7.612100E-02
Diabetic-vs-NonDiabetic
9.050400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.183600E-02
Normal-vs-NoPancreatitis
9.056200E-02
Pancreatitis-vs-NoPancreatitis
7.387400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.276200E-02
Normal-vs-N1
1.316810E-01
N0-vs-N1
1.390780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.638100E-02
Normal-vs-TP53-NonMutant
6.370100E-02
TP53-Mutant-vs-TP53-NonMutant
9.481600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
